// App-Quantinova.ai

e16519 : Bio-miR A prognostic microRNA-based signature for localized clear cell renal cell carcinoma.

Researchers

Presenter

  • Alvaro Pinto

Principal Investigators

  • Jesus Miranda Poma

  • Naveen Vasudev

  • Eugenia García-Fernández

  • Rocio Lopez Vacas

  • Natalia Miranda

  • Michelle Wilson

  • Elena López-Camacho

  • Ana Pertejo

  • Maria Isabel Lumbreras-Herrera

  • Joanne C Brown

  • Andrea Zapater-Moros

  • Guillermo De Velasco

  • Daniel E. Castellano

  • María Pilar González-Peramato

  • Enrique Espinosa

  • Rosamonde Banks

  • Juan Angel Fresno-Vara

  • Angelo Gámez-Pozo

Medical Centers

  • Department of Medical Oncology, Doce de Octubre University Hospital, Madrid, Spain

  • Molecular Oncology Lab, University Hospital La Paz, Madrid, Spain

  • Medical Oncology Department, QuironSalud Hospitales, Madrid, Spain

  • Clinical and Biomedical Proteomics Group, Leeds Institute of Medical Research at St James's, University of Leeds, St. James's University Hospital, Leeds, United Kingdom

  • Pathology Department, University Hospital La Fe, Valencia, Spain

  • Molecular Oncology Lab, University Hospital La Paz, Madrid, Spain

  • Pathology Department, University Hospital 12 de Octubre, Madrid, Spain

  • Molecular Oncology Lab, University Hospital La Paz-IdiPAZ, Biomedica Molecular Medicine SL, Madrid, Spain

  • Medical Oncology Division, University Hospital La Paz, Madrid, Spain

  • Medical Oncology Department. Hospital 12 de Octubre, Madrid, Spain

  • Medical Oncology Department, University Hospital La Paz, Biomedical Research Networking Center on Oncology-CIBERONC, ISCIII, Madrid, Spain

  • Medical Oncology Department, University Hospital La Paz, Biomedical Research Networking Center on Oncology-CIBERONC, ISCIII, Madrid, Spain

Locations

  • Spain

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Clear cell renal carcinoma

Biomarkers

  • N/A

Drug/Treatment

  • Pembrolizumab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • III

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved